Short-Acting Insulin Market, By Drug (NovoLog, Humalog, Humulin R, Apidra, Fiasp, Lyumjev, and Others), By Route of Administration, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

TABLE OF CONTENT

1.    Short-Acting Insulin Market Overview
1.1.    Study Scope
1.2.    Market Estimation Years
2.    Executive Summary
2.1.    Market Snippet
2.1.1.    Short-Acting Insulin Market Snippet by Drug
2.1.2.    Short-Acting Insulin Market Snippet by Route of Administration
2.1.3.    Short-Acting Insulin Market Snippet by Distribution Channel
2.1.4.    Short-Acting Insulin Market Snippet by Country
2.1.5.    Short-Acting Insulin Market Snippet by Region
2.2.    Competitive Insights
3.    Short-Acting Insulin Key Market Trends
3.1.    Short-Acting Insulin Market Drivers 
3.1.1.    Impact Analysis of Market Drivers
3.2.    Short-Acting Insulin Market Restraints
3.2.1.    Impact Analysis of Market Restraints
3.3.    Short-Acting Insulin Market Opportunities
3.4.    Short-Acting Insulin Market Future Trends
4.    Short-Acting Insulin Industry Study
4.1.    PEST Analysis
4.2.    Porter’s Five Forces Analysis
4.3.    Growth Prospect Mapping
4.4.    Regulatory Framework Analysis
5.    Short-Acting Insulin Market: Impact of Escalating Geopolitical Tensions
5.1.    Impact of COVID-19 Pandemic
5.2.    Impact of Russia-Ukraine War
5.3.    Impact of Middle East Conflicts
6.    Short-Acting Insulin Market Landscape
6.1.    Short-Acting Insulin Market Share Analysis, 2025
6.2.    Breakdown Data, by Key Manufacturer
6.2.1.    Established Players’ Analysis
6.2.2.    Emerging Players’ Analysis
7.    Short-Acting Insulin Market – By Drug
7.1.    Overview
7.1.1.    Segment Share Analysis, By Drug, 2025 & 2033 (%)
7.1.2.    NovoLog (Insulin Aspart)
7.1.3.    Humalog (Insulin Lispro)
7.1.4.    Humulin R (Regular Human Insulin)
7.1.5.    Apidra (Insulin Glulisine)
7.1.6.    Fiasp (Fast-Acting Insulin Aspart)
7.1.7.    Lyumjev (Ultra Rapid Insulin Lispro) 
8.    Short-Acting Insulin Market – By Route of Administration
8.1.    Overview
8.1.1.    Segment Share Analysis, By Route of Administration, 2025 & 2033 (%)
8.1.2.    Subcutaneous Injection
8.1.3.    Intravenous Administration 
9.    Short-Acting Insulin Market – By Distribution Channel
9.1.    Overview
9.1.1.    Segment Share Analysis, By Distribution Channel, 2025 & 2033 (%)
9.1.2.    Hospital Pharmacies
9.1.3.    Retail Pharmacies
9.1.4.    Online Pharmacies 
10.    Short-Acting Insulin Market– By Geography
10.1.    Introduction
10.1.1.    Segment Share Analysis, By Geography, 2025 & 2033 (%)
10.2.    North America
10.2.1.    Overview
10.2.2.    Short-Acting Insulin Key Manufacturers in North America 
10.2.3.    North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.2.4.    North America Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.2.5.    North America Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.2.6.    North America Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.2.7.    U.S.
10.2.7.1.    Overview
10.2.7.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.2.7.3.    U.S. Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.2.7.4.    U.S. Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.2.7.5.    U.S. Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.2.8.    Canada
10.2.8.1.    Overview
10.2.8.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.2.8.3.    Canada Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.2.8.4.    Canada Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.2.8.5.    Canada Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.3.    Europe
10.3.1.    Overview
10.3.2.    Short-Acting Insulin Key Manufacturers in Europe
10.3.3.    Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.3.4.    Europe Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.3.5.    Europe Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.3.6.    Europe Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.3.7.    Germany
10.3.7.1.    Overview
10.3.7.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.7.3.    Germany Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.3.7.4.    Germany Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.3.7.5.    Germany Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.3.8.    UK
10.3.8.1.    Overview
10.3.8.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.8.3.    UK Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.3.8.4.    UK Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.3.8.5.    UK Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.3.9.    France
10.3.9.1.    Overview
10.3.9.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.9.3.    France Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.3.9.4.    France Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.3.9.5.    France Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.3.10.    Italy
10.3.10.1.    Overview
10.3.10.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.10.3.    Italy Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.3.10.4.    Italy Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.3.10.5.    Italy Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.3.11.    Spain
10.3.11.1.    Overview
10.3.11.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.11.3.    Spain Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.3.11.4.    Spain Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.3.11.5.    Spain Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.3.12.    The Netherlands
10.3.12.1.    Overview
10.3.12.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.12.3.    The Netherlands Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.3.12.4.    The Netherlands Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.3.12.5.    The Netherlands Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.3.13.    Sweden
10.3.13.1.    Overview
10.3.13.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.13.3.    Sweden Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.3.13.4.    Sweden Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.3.13.5.    Sweden Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.3.14.    Russia
10.3.14.1.    Overview
10.3.14.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.14.3.    Russia Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.3.14.4.    Russia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.3.14.5.    Russia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.3.15.    Poland
10.3.15.1.    Overview
10.3.15.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.15.3.    Poland Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.3.15.4.    Poland Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.3.15.5.    Poland Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.3.16.    Denmark
10.3.16.1.    Overview
10.3.16.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.16.3.    Denmark Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.3.16.4.    Denmark Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.3.16.5.    Denmark Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.3.17.    Rest of Europe
10.3.17.1.    Overview
10.3.17.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.17.3.    Rest of the Europe Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.3.17.4.    Rest of the Europe Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.3.17.5.    Rest of the Europe Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.4.    Asia Pacific (APAC)
10.4.1.    Overview
10.4.2.    Short-Acting Insulin Key Manufacturers in Asia Pacific
10.4.3.    APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.4.4.    APAC Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.4.5.    APAC Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.4.6.    APAC Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.4.7.    China
10.4.7.1.    Overview
10.4.7.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.7.3.    China Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.4.7.4.    China Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.4.7.5.    China Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.4.8.    India
10.4.8.1.    Overview
10.4.8.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.8.3.    India Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.4.8.4.    India Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.4.8.5.    India Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.4.9.    Japan
10.4.9.1.    Overview
10.4.9.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.9.3.    Japan Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.4.9.4.    Japan Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.4.9.5.    Japan Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.4.10.    South Korea
10.4.10.1.    Overview
10.4.10.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.10.3.    South Korea Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.4.10.4.    South Korea Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.4.10.5.    South Korea Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.4.11.    Australia
10.4.11.1.    Overview
10.4.11.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.11.3.    Australia Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.4.11.4.    Australia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.4.11.5.    Australia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.4.12.    Indonesia
10.4.12.1.    Overview
10.4.12.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.12.3.    Indonesia Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.4.12.4.    Indonesia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.4.12.5.    Indonesia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.4.13.    Thailand
10.4.13.1.    Overview
10.4.13.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.13.3.    Thailand Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.4.13.4.    Thailand Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.4.13.5.    Thailand Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.4.14.    Philippines
10.4.14.1.    Overview
10.4.14.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.14.3.    Philippines Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.4.14.4.    Philippines Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.4.14.5.    Philippines Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.4.15.    Taiwan
10.4.15.1.    Overview
10.4.15.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.15.3.    Taiwan Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.4.15.4.    Taiwan Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.4.15.5.    Taiwan Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.4.16.    Vietnam
10.4.16.1.    Overview
10.4.16.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.16.3.    Vietnam Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.4.16.4.    Vietnam Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.4.16.5.    Vietnam Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.4.17.    Rest of APAC
10.4.17.1.    Overview
10.4.17.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.17.3.    Rest of APAC Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.4.17.4.    Rest of APAC Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.4.17.5.    Rest of APAC Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.5.    Latin America (LATAM)
10.5.1.    Overview
10.5.2.    Short-Acting Insulin Key Manufacturers in Latin America
10.5.3.    LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.5.4.    LATAM Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.5.5.    LATAM Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.5.6.    LATAM Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.5.7.    Brazil
10.5.7.1.    Overview
10.5.7.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.7.3.    Brazil Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.5.7.4.    Brazil Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.5.7.5.    Brazil Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.5.8.    Mexico
10.5.8.1.    Overview
10.5.8.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.8.3.    Mexico Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.5.8.4.    Mexico Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.5.8.5.    Mexico Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.5.9.    Argentina
10.5.9.1.    Overview
10.5.9.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.9.3.    Argentina Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.5.9.4.    Argentina Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.5.9.5.    Argentina Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.5.10.    Colombia
10.5.10.1.    Overview
10.5.10.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.10.3.    Colombia Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.5.10.4.    Colombia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.5.10.5.    Colombia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.5.11.    Rest of LATAM
10.5.11.1.    Overview
10.5.11.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.11.3.    Rest of LATAM Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.5.11.4.    Rest of LATAM Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.5.11.5.    Rest of LATAM Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.6.    Middle East and Africa (MEA)
10.6.1.    Overview
10.6.2.    Short-Acting Insulin Key Manufacturers in Middle East and Africa
10.6.3.    MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.6.4.    MEA Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.6.5.    MEA Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.6.6.    MEA Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.6.7.    Saudi Arabia
10.6.7.1.    Overview
10.6.7.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.7.3.    Saudi Arabia Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.6.7.4.    Saudi Arabia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.6.7.5.    Saudi Arabia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.6.8.    UAE
10.6.8.1.    Overview
10.6.8.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.8.3.    UAE Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.6.8.4.    UAE Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.6.8.5.    UAE Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.6.9.    Israel
10.6.9.1.    Overview
10.6.9.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.9.3.    Israel Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.6.9.4.    Israel Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.6.9.5.    Israel Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.6.10.    Turkey
10.6.10.1.    Overview
10.6.10.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.10.3.    Turkey Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.6.10.4.    Turkey Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.6.10.5.    Turkey Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.6.11.    Algeria
10.6.11.1.    Overview
10.6.11.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.11.3.    Algeria Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.6.11.4.    Algeria Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.6.11.5.    Algeria Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.6.12.    Egypt
10.6.12.1.    Overview
10.6.12.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.12.3.    Egypt Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.6.12.4.    Egypt Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.6.12.5.    Egypt Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.6.13.    Iran
10.6.13.1.    Overview
10.6.13.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.13.3.    Iran Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.6.13.4.    Iran Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.6.13.5.    Iran Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.6.14.    Qatar
10.6.14.1.    Overview
10.6.14.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.14.3.    Qatar Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.6.14.4.    Qatar Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.6.14.5.    Qatar Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.6.15.    Rest of MEA
10.6.15.1.    Overview
10.6.15.2.    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.15.3.    Rest of MEA Market Size and Forecast, By Drug, 2020 - 2033 (US$ Million)
10.6.15.4.    Rest of MEA Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
10.6.15.5.    Rest of MEA Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.    Key Vendor Analysis- Short-Acting Insulin Industry 
11.1.    Competitive Benchmarking
11.1.1.    Competitive Dashboard
11.1.2.    Competitive Positioning
11.2.    Company Profiles
11.2.1.    Novo Nordisk A/S
11.2.2.    Sanofi
11.2.3.    Eli Lilly and Company
11.2.4.    Biocon Biologics
11.2.5.    Wockhardt Ltd.
11.2.6.    Julphar
11.2.7.    Gan & Lee Pharmaceuticals
11.2.8.    Tonghua Dongbao Pharmaceutical
11.2.9.    United Laboratories International Holdings
11.2.10.    Geropharm
11.2.11.    Verily
11.2.12.    Sensile Medical 
11.2.13.    Others
12.    360 Degree AnalystView
13.    Appendix
13.1.    Research Methodology
13.2.    References
13.3.    Abbreviations
13.4.    Disclaimer
13.5.    Contact Us

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL SHORT-ACTING INSULIN MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Novo Nordisk A/S
• Sanofi
• Eli Lilly and Company
• Biocon Biologics
• Wockhardt Ltd.
• Julphar
• Gan & Lee Pharmaceuticals
• Tonghua Dongbao Pharmaceutical
• United Laboratories International Holdings
• Geropharm
• Verily
• Sensile Medical
• Others

GLOBAL SHORT-ACTING INSULIN MARKET, BY DRUG - MARKET ANALYSIS, 2019 - 2032

• NovoLog (Insulin Aspart)
• Humalog (Insulin Lispro)
• Humulin R (Regular Human Insulin)
• Apidra (Insulin Glulisine)
• Fiasp (Fast-Acting Insulin Aspart)
• Lyumjev (Ultra Rapid Insulin Lispro)
• Others

GLOBAL SHORT-ACTING INSULIN MARKET, BY ROUTE OF ADMINISTRATION - MARKET ANALYSIS, 2019 - 2032

• Subcutaneous Injection
• Intravenous Administration

GLOBAL SHORT-ACTING INSULIN MARKET, BY DISTRIBUTION CHANNEL - MARKET ANALYSIS, 2019 - 2032

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

GLOBAL SHORT-ACTING INSULIN MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America

• U.S.
• Canada

Europe

• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Rest of APAC

Latin America

• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM

The Middle East and Africa

• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA